Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus [Phase 1, Phase 2]

View source ↗

Summary

This update states that CDI-988 is being evaluated for efficacy, safety, and pharmacokinetics in healthy adults after a norovirus challenge in a Phase 1/2 study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Norovirus Infection

Drugs mentioned

• CDI-988

Snippet

Sponsor: Cocrystal Pharma, Inc. | Conditions: Norovirus | Phase 1, Phase 2 | Status: RECRUITING